RT Journal Article
SR Electronic
T1 <sup>18</sup>F-FDG PET/CT for Staging and Restaging of Breast Cancer
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 17S
OP 26S
DO 10.2967/jnumed.115.157859
VO 57
IS Supplement 1
A1 David Groheux
A1 Alexandre Cochet
A1 Olivier Humbert
A1 Jean-Louis Alberini
A1 Elif Hindié
A1 David Mankoff
YR 2016
UL http://jnm.snmjournals.org/content/57/Supplement_1/17S.abstract
AB Many studies have pointed out the role of 18F-FDG PET/CT (or 18F-FDG PET) in patients with clinical stage III or II breast cancer. 18F-FDG PET/CT might advantageously replace other staging procedures, such as bone scanning and possibly contrast-enhanced CT of the thorax or abdomen–pelvis. We discuss the findings, locoregional or distant, that can be expected in different categories of breast cancer and their impact on prognosis and management. We also discuss the role of 18F-FDG PET/CT in restaging and how 18F-FDG PET/CT compares with conventional techniques in restaging for patients with suspected disease recurrence. We conclude with some recommendations for clinical practice and future research.